Pregabalin Capsule
Product Images NDC 72162-1541

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 72162-1541). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721621541)

This is a description of Pregabalin capsules, which contains 25mg of USP. The manufacturer is ScieGen Pharmaceuticals Inc., and it was repackaged by Bryant Ranch Prepack, Inc. The drug should be stored at a temperature of 20°-25°C (68°-77°F). It comes with 90 capsules, and the NDC is 72162-1541-4. The text contains a cautionary statement to keep the drug out of reach of children.*

FDA Label Image

Figure 1 (Pregabalin Fig01)

The data provided is not available for generating a useful description.*

FDA Label Image

Figure 2 (Pregabalin Fig02)

This appears to be a chart showing the percent improvement in pain from baseline for patients taking Pregabalin 160mg for three days. The chart displays percentages ranging from 2% to 100%. There are additional numbers listed, but their significance is unclear without further context.*

FDA Label Image

Figure 3 (Pregabalin Fig03)

This appears to be a chart or table showing percentages and medication dosages for patients with pain. It is not clear how the chart is organized or what the specific data points represent. Therefore, a useful description cannot be generated with the given text.*

FDA Label Image

Figure 4 (Pregabalin Fig04)

FDA Label Image

Figure 5 (Pregabalin Fig05)

This is a medical document that reports on the effects of three treatments on patients. The treatments are Fregabalin 100 mg three times a day, Pregataiin 80 mg three times a day, and Placebo. The document includes a chart that indicates the percentage of patients who improved during the study. There is also a chart that shows the percentage improvement in pain from baseline, with numbers ranging from 0.8 to 100.*

FDA Label Image

Figure 6 (Pregabalin Fig06)

FDA Label Image

Figure 7 (Pregabalin Fig07)

FDA Label Image

Figure 9 (Pregabalin Fig08)

The text provides a graph showing the percent improvement in pain from baseline for Pregabalin at 300mg and 450mg daily doses, as well as a placebo group. The graph plots the percentage of patients improved against the percentage improvement in pain from baseline. There is not enough information to provide a specific description of the study or its findings beyond what is shown in the graph.*

FDA Label Image

Figure 10 (Pregabalin Fig09)

This appears to be a chart or graph displaying the estimated percentage of subjects without LTR for two groups (Progabain and Placebo) over a period of time (0 to 180 days). The x-axis shows the days and the y-axis shows the percentages. It is not clear what the abbreviation "LTR" stands for or what the context of this chart is.*

FDA Label Image

Figure 11 (Pregabalin Fig10)

FDA Label Image

Figure 12 (Pregabalin Fig11)

This is a graph showing the percentage of subjects who improved from baseline to week 16 BOCF (Brought Forward Last Observation Carried Forward) while taking either pregabalin or placebo. The scale ranges from 100 to 280, with significant improvement seen in the pregabalin group compared to placebo.*

FDA Label Image

Cockcroft And Gault Equation (Pregabalin Formula)

This is a calculation to estimate the estimated glomerular filtration rate, or GFR, in adults using their age, weight, and serum creatinine levels. The equation involves subtracting the person's age in years from 140, then multiplying that result by their weight in kilograms. For female patients, the result is then multiplied by 0.85. Finally, the product is multiplied by the person's serum creatinine level in milligrams per deciliter, and divided by 72. This equation is often used to assess kidney function.*

FDA Label Image

Chemical Structure (Pregabalin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.